Omega Healthcare Investors, Inc. (NYSE:OHI) Receives Consensus Rating of “Moderate Buy” from Analysts

Omega Healthcare Investors, Inc. (NYSE:OHI) has received a consensus recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price target among analysts that have covered the stock in the last year is $43.3750.

A number of research analysts have recently weighed in on the stock. Scotiabank increased their target price on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the company a “sector perform” rating in a research report on Thursday, August 28th. Raymond James Financial reissued an “outperform” rating on shares of Omega Healthcare Investors in a research report on Tuesday. Wells Fargo & Company increased their target price on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the company an “overweight” rating in a research report on Wednesday, August 27th. Truist Financial raised their price objective on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a “hold” rating in a report on Wednesday. Finally, Royal Bank Of Canada raised their price objective on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a “sector perform” rating in a report on Thursday, August 7th.

Insider Buying and Selling

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm’s stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the transaction, the director directly owned 18,654 shares of the company’s stock, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. boosted its holdings in Omega Healthcare Investors by 3.1% in the 2nd quarter. Vanguard Group Inc. now owns 40,765,481 shares of the real estate investment trust’s stock worth $1,494,055,000 after buying an additional 1,210,595 shares during the period. State Street Corp boosted its holdings in Omega Healthcare Investors by 4.8% in the 2nd quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust’s stock worth $534,792,000 after buying an additional 671,473 shares during the period. Geode Capital Management LLC boosted its holdings in Omega Healthcare Investors by 4.6% in the 2nd quarter. Geode Capital Management LLC now owns 7,377,761 shares of the real estate investment trust’s stock worth $270,426,000 after buying an additional 326,595 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in Omega Healthcare Investors by 2.4% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 4,201,353 shares of the real estate investment trust’s stock valued at $153,980,000 after purchasing an additional 100,462 shares during the period. Finally, Dimensional Fund Advisors LP boosted its holdings in Omega Healthcare Investors by 4.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,058,107 shares of the real estate investment trust’s stock valued at $154,533,000 after purchasing an additional 165,554 shares during the period. 65.25% of the stock is owned by institutional investors.

Omega Healthcare Investors Stock Up 0.7%

Omega Healthcare Investors stock opened at $42.77 on Friday. Omega Healthcare Investors has a twelve month low of $35.04 and a twelve month high of $44.42. The firm has a 50 day moving average price of $39.51 and a 200-day moving average price of $37.96. The company has a market capitalization of $12.62 billion, a P/E ratio of 26.40, a P/E/G ratio of 2.25 and a beta of 0.71. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96.

Omega Healthcare Investors (NYSE:OHI) last released its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, beating analysts’ consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The firm had revenue of $235.60 million during the quarter, compared to the consensus estimate of $248.49 million. During the same period in the prior year, the firm earned $0.71 EPS. The company’s revenue was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. As a group, equities analysts predict that Omega Healthcare Investors will post 2.86 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were issued a $0.67 dividend. The ex-dividend date of this dividend was Monday, August 4th. This represents a $2.68 annualized dividend and a yield of 6.3%. Omega Healthcare Investors’s dividend payout ratio (DPR) is 165.43%.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.